LYNGE, DENMARK — WSA reported 3% organic revenue growth in the third quarter of its 2025/26 financial year (April 1–June 30, 2026), with revenue reaching €624 million. EBITDA before special items increased 12% to €119 million, while the corresponding margin rose 2 percentage points to 19.1%....
Continue reading at Hearing Health Matters
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a financial performance report with no direct implications for clinical practice.
WSA's continued revenue growth and margin expansion signals ongoing financial health in the broader hearing industry supply chain, which can influence product availability, pricing, and investment in innovation.
- 01WSA posted 3% organic revenue growth in Q3 FY 2025/26 (April–June 2026).
- 02Total quarterly revenue reached €624 million.
- 03EBITDA before special items rose 12% to €119 million.
- 04EBITDA margin improved by 2 percentage points, indicating better profitability.
- 05Results reflect a financial report, not a clinical or product development announcement.
WSA achieved 3% organic revenue growth in Q3 FY 2025/26.
press releasesupportedWSA revenue was €624 million in Q3 FY 2025/26.
press releasesupportedEBITDA before special items increased 12% to €119 million.
press releasesupportedEBITDA margin improved by 2 percentage points year-over-year.
press releasesupported
